$INVA
Innoviva Inc Stock $inva

$inva Overview Financials Valuation SEC Filings Company Website

2013 Q1 Form 10-Q Financial Statement

#000110465913036028 Filed on May 01, 2013

Income Statement

Concept	2013 Q1	2012 Q1
Revenue	$1.344M	$127.1M
YoY Change	-98.94%	1917.46%
Cost Of Revenue	$0.00
YoY Change
Gross Profit	$1.344M
YoY Change
Gross Profit Margin	100.0%
Selling, General & Admin	$8.315M	$7.900M
YoY Change	5.25%	9.72%
% of Gross Profit	618.68%
Research & Development	$26.42M	$33.20M
YoY Change	-20.44%	61.96%
% of Gross Profit	1965.48%
Depreciation & Amortization	$1.898M	$1.910M
YoY Change	-0.63%	12.35%
% of Gross Profit	141.22%
Operating Expenses	$34.73M	$41.06M
YoY Change	-15.41%	48.76%
Operating Profit	-$33.39M	$86.04M
YoY Change	-138.8%
Interest Expense	$2.736M	$1.502M
YoY Change	82.16%	-207.29%
% of Operating Profit		1.75%
Other Income/Expense, Net	-$1.422M
YoY Change
Pretax Income	-$10.70M	$84.60M
YoY Change	-112.65%	-472.69%
Income Tax	$0.00	$0.00
% Of Pretax Income		0.0%
Net Earnings	-$37.40M	$84.60M
YoY Change	-144.21%	-472.69%
Net Earnings / Revenue	-2782.74%	66.56%
Basic Earnings Per Share	-$0.39	$1.01
Diluted Earnings Per Share	-$0.39	$0.93
COMMON SHARES
Basic Shares Outstanding	96.38M shares	83.59M shares
Diluted Shares Outstanding	96.38M shares	92.08M shares

Balance Sheet

Concept	2013 Q1	2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$459.1M	$200.2M
YoY Change	129.3%	-31.86%
Cash & Equivalents	$266.1M	$14.31M
Short-Term Investments	$193.0M	$185.9M
Other Short-Term Assets	$5.200M	$3.900M
YoY Change	33.33%	-32.76%
Inventory	$8.049M
Prepaid Expenses
Receivables	$2.200M	$100.0K
Other Receivables	$0.00	$200.0K
Total Short-Term Assets	$474.5M	$204.3M
YoY Change	132.26%	-31.97%
LONG-TERM ASSETS
Property, Plant & Equipment	$9.010M	$10.10M
YoY Change	-10.79%	-3.81%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$99.30M
YoY Change
Other Assets	$7.682M	$3.200M
YoY Change	140.06%	-20.0%
Total Long-Term Assets	$117.0M	$13.40M
YoY Change	773.19%	-9.46%
TOTAL ASSETS
Total Short-Term Assets	$474.5M	$204.3M
Total Long-Term Assets	$117.0M	$13.40M
Total Assets	$591.5M	$217.7M
YoY Change	171.71%	-30.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.525M	$5.300M
YoY Change	-33.49%	140.91%
Accrued Expenses	$16.10M	$14.50M
YoY Change	11.03%	47.96%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$29.46M	$25.60M
YoY Change	15.09%	-23.35%
LONG-TERM LIABILITIES
Long-Term Debt	$460.0M	$172.5M
YoY Change	166.67%	0.0%
Other Long-Term Liabilities	$10.50M	$13.50M
YoY Change	-22.22%	-90.15%
Total Long-Term Liabilities	$470.5M	$186.0M
YoY Change	152.96%	-39.9%
TOTAL LIABILITIES
Total Short-Term Liabilities	$29.46M	$25.60M
Total Long-Term Liabilities	$470.5M	$186.0M
Total Liabilities	$500.0M	$211.6M
YoY Change	136.29%	-38.29%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.372B
YoY Change
Common Stock	$1.463B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$91.51M	$6.100M
YoY Change
Total Liabilities & Shareholders Equity	$591.5M	$217.7M
YoY Change	171.71%	-30.91%

Cashflow Statement

Concept	2013 Q1	2012 Q1
OPERATING ACTIVITIES
Net Income	-$37.40M	$84.60M
YoY Change	-144.21%	-472.69%
Depreciation, Depletion And Amortization	$1.898M	$1.910M
YoY Change	-0.63%	12.35%
Cash From Operating Activities	-$31.60M	-$41.30M
YoY Change	-23.49%	59.46%
INVESTING ACTIVITIES
Capital Expenditures	$740.0K	$1.103M
YoY Change	-32.91%	-178.79%
Acquisitions
YoY Change
Other Investing Activities	-$44.30M	$9.500M
YoY Change	-566.32%	9400.0%
Cash From Investing Activities	-$45.00M	$8.400M
YoY Change	-635.71%	-800.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$2.991M	$2.532M
YoY Change	18.13%	-78.36%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	247.9M	2.500M
YoY Change	9816.0%	-78.63%
NET CHANGE
Cash From Operating Activities	-31.60M	-41.30M
Cash From Investing Activities	-45.00M	8.400M
Cash From Financing Activities	247.9M	2.500M
Net Change In Cash	171.3M	-30.40M
YoY Change	-663.49%	97.4%
FREE CASH FLOW
Cash From Operating Activities	-$31.60M	-$41.30M
Capital Expenditures	$740.0K	$1.103M
Free Cash Flow	-$32.34M	-$42.40M
YoY Change	-23.73%	73.07%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman;" size="2">Use of Management’s Estimates</font></b></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in;"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman;" size="2">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates.</font></p> </div>
CY2013Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3531000	USD
CY2013Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4518000	USD
CY2013Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-37360000	USD
CY2012Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	84594000	USD
CY2013Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-37360000	USD
CY2012Q1	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	1500000	USD
CY2012Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	86094000	USD
CY2013Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	99181000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	2802000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	96379000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	86292000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	2702000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	83590000	shares
CY2012Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1822000	shares
CY2012Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	6668000	shares
CY2013Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	19725000	shares
CY2012Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4641000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	96379000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	92080000	shares
CY2013Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	550210000	USD
CY2012Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	335866000	USD
CY2013Q1	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	121000	USD
CY2012Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	127000	USD
CY2013Q1	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	29000	USD
CY2012Q4	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	28000	USD
CY2012Q4	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	335965000	USD
CY2013Q1	thrx	Marketable Securities Average Contractual Maturity Period MarketableSecuritiesAverageContractualMaturityPeriod	P9M
CY2013Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	100000	USD
CY2013Q1	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	550302000	USD
CY2013Q1	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	11500000	USD
CY2013Q1	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	10100000	USD
CY2012Q4	us-gaap	Convertible Subordinated Debt Noncurrent ConvertibleSubordinatedDebtNoncurrent	172500000	USD
CY2013Q1	us-gaap	Convertible Subordinated Debt Noncurrent ConvertibleSubordinatedDebtNoncurrent	460000000	USD
CY2013Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2012Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	153640000	USD
CY2012Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6550000	USD
CY2013Q1	us-gaap	Due From Employees Noncurrent DueFromEmployeesNoncurrent	140000	USD
CY2013Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6095000	USD
CY2012Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6235000	USD
CY2013Q1	dei	Entity Registrant Name EntityRegistrantName	THERAVANCE INC
CY2013Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001080014
CY2013Q1	dei	Document Type DocumentType	10-Q
CY2013Q1	dei	Document Period End Date DocumentPeriodEndDate	2013-03-31
CY2013Q1	dei	Amendment Flag AmendmentFlag	false
CY2013Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2013Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	99453571	shares
CY2013Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2012Q4	thrx	Receivables From Collaboration Partners ReceivablesFromCollaborationPartners	1064000	USD
CY2012Q4	us-gaap	Due From Employees Current DueFromEmployeesCurrent	100000	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3966000	USD
CY2012Q4	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	7514000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	261133000	USD
CY2012Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	95194000	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	833000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9154000	USD
CY2012Q4	us-gaap	Due From Employees Noncurrent DueFromEmployeesNoncurrent	140000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2128000	USD
CY2012Q4	us-gaap	Assets Assets	368582000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5377000	USD
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9002000	USD
CY2012Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2072000	USD
CY2012Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2372000	USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4593000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	29966000	USD
CY2012Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	5074000	USD
CY2012Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	6014000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	984000	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1488447000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	99000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1334502000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	155028000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	368582000	USD
CY2013Q1	us-gaap	Assets Current AssetsCurrent	474512000	USD
CY2013Q1	us-gaap	Assets Assets	591519000	USD
CY2013Q1	us-gaap	Liabilities Current LiabilitiesCurrent	29464000	USD
CY2013Q1	us-gaap	Stockholders Equity StockholdersEquity	91511000	USD
CY2013Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	123000	USD
CY2013Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	98379000	shares
CY2012Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	33202000	USD
CY2012Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7857000	USD
CY2012Q1	us-gaap	Operating Expenses OperatingExpenses	41059000	USD
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	86040000	USD
CY2012Q1	us-gaap	Interest Expense InterestExpense	1502000	USD
CY2013Q1	us-gaap	Operating Expenses OperatingExpenses	34731000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-33387000	USD
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.01
CY2012Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.93
CY2013Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	1322000	USD
CY2012Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	1430000	USD
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-37367000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-25000	USD
CY2012Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	84569000	USD
CY2012Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1910000	USD
CY2012Q1	us-gaap	Share Based Compensation ShareBasedCompensation	6235000	USD
CY2012Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-160000	USD
CY2012Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	375000	USD
CY2012Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	48000	USD
CY2012Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-5363000	USD
CY2012Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	143000	USD
CY2012Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-127100000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-41328000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-31631000	USD
CY2012Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1103000	USD
CY2012Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	35671000	USD
CY2012Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	45158000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	8384000	USD
CY2012Q1	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	56000	USD
CY2012Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2532000	USD
CY2012Q1	thrx	Collaborative Arrangements Revenue CollaborativeArrangementsRevenue	127099000	USD
CY2013Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	192986000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	2476000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-30468000	USD
CY2013Q1	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	1000	USD
CY2013Q1	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable	100000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	171221000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	247864000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14310000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	94849000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	266070000	USD
CY2013Q1	us-gaap	Inventory Net InventoryNet	8049000	USD
CY2012Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	1294000	USD
CY2013Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	0	USD
CY2013Q1	thrx	Collaborative Arrangements Revenue CollaborativeArrangementsRevenue	1344000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44778000	USD
CY2013Q1	thrx	Marketable Securities Maximum Contractual Maturity Period MarketableSecuritiesMaximumContractualMaturityPeriod	P2Y
CY2013Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7682000	USD
CY2013Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	104125000	USD
CY2013Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	54753000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-45012000	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2991000	USD
CY2012Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	USD
CY2013Q1	thrx	Debt Instrument Change In Fair Value Of Debt Offering Between Pricing Date And Closing Date DebtInstrumentChangeInFairValueOfDebtOfferingBetweenPricingDateAndClosingDate	1400000	USD
CY2012Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	56000	USD
CY2013Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	-1237000	USD
CY2013Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-1422000	USD
CY2013Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2481000	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Subordinated Long Term Debt ProceedsFromIssuanceOfSubordinatedLongTermDebt	281673000	USD
CY2012Q4	thrx	Fair Value Assets Level2 FairValueAssetsLevel2	11400000	USD
CY2013Q1	thrx	Receivables From Collaboration Partners ReceivablesFromCollaborationPartners	2217000	USD
CY2013Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5190000	USD
CY2013Q1	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	8049000	USD
CY2013Q1	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	254000	USD
CY2013Q1	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	99342000	USD
CY2013Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	833000	USD
CY2013Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9010000	USD
CY2013Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	99304000	shares
CY2013Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6054000	USD
CY2013Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3525000	USD
CY2013Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5128000	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	92000	USD
CY2013Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2678000	USD
CY2013Q1	us-gaap	Interest Payable Current InterestPayableCurrent	2198000	USD
CY2013Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	9881000	USD
CY2013Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	5672000	USD
CY2013Q1	us-gaap	Common Stock Value CommonStockValue	993000	USD
CY2013Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	4872000	USD
CY2013Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1462288000	USD
CY2013Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26416000	USD
CY2013Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1371862000	USD
CY2013Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	591519000	USD
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8315000	USD
CY2013Q1	us-gaap	Interest Expense InterestExpense	2736000	USD
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
CY2013Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-7000	USD
CY2013Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1898000	USD
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	6095000	USD
CY2013Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	1153000	USD
CY2013Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1224000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-221000	USD
CY2013Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3176000	USD
CY2013Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	174000	USD
CY2013Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	202000	USD
CY2013Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	4946000	USD
CY2013Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	740000	USD
CY2012Q4	thrx	Fair Value Assets Level1 FairValueAssetsLevel1	10100000	USD
CY2013Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	5000000	USD
CY2013Q1	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	36800000	USD
CY2012Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	5668000	USD
CY2012Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1846000	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	7514000	USD

Files In Submission

Name	View Source	Status
0001104659-13-036028-index-headers.html	Edgar Link	pending
0001104659-13-036028-index.html	Edgar Link	pending
0001104659-13-036028.txt	Edgar Link	pending
0001104659-13-036028-xbrl.zip	Edgar Link	pending
a13-7731_110q.htm	Edgar Link	pending
a13-7731_1ex10d42.htm	Edgar Link	pending
a13-7731_1ex31d1.htm	Edgar Link	pending
a13-7731_1ex31d2.htm	Edgar Link	pending
a13-7731_1ex32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
g77311kk11i001.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
thrx-20130331.xml	Edgar Link	completed
thrx-20130331.xsd	Edgar Link	pending
thrx-20130331_cal.xml	Edgar Link	unprocessable
thrx-20130331_def.xml	Edgar Link	unprocessable
thrx-20130331_lab.xml	Edgar Link	unprocessable
thrx-20130331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INVA
Innoviva Inc Stock $inva

2013 Q1 Form 10-Q Financial Statement

#000110465913036028 Filed on May 01, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INVA Innoviva Inc Stock $inva

2013 Q1 Form 10-Q Financial Statement

#000110465913036028 Filed on May 01, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INVA
Innoviva Inc Stock $inva